The neurobiology of methamphetamine induced psychosis

Frontiers in Human Neuroscience

Volumn 8, Issue JULY, 2014, Pages

  Hsieh, Jennifer H ^a   Stein, Dan J ^a   Howells, Fleur M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cortex; GABA; Neural circuitry; Neurotoxicity; Schizophrenia; Sensitization

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BASAL GANGLION; BRAIN CORTEX; COGNITION; DRUG INDUCED DISEASE; DSM-5; GABAERGIC SYSTEM; HUMAN; INTERNEURON; LIMBIC CORTEX; METHAMPHETAMINE INDUCED PSYCHOSIS; NEUROBIOLOGY; NIGRONEOSTRIATAL SYSTEM; REVIEW; SCHIZOPHRENIA; VERBALIZATION;

EID: 84904599593     PISSN: None     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2014.00537     Document Type: Review

References (163)

1. Albin, R. L., Makowiec, R. L., Hollingsworth, Z. R., Dure, L. S. 4th., Penney, J. B., and Young, A. B. (1992). Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience46, 35-48. doi: 10.1016/0306-4522(92)90006-N
2. Alexander, G. E., and Crutcher, M. D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neuros c i.13, 266-271. doi: 10.1016/0166-2236(90)90107-L
3. Altar, C. A., and Hauser, K. (1987). Topography of substantia nigra innervation by d1 receptor-containing striatal neurons. Brain Res.410, 1-11. doi: 10.1016/S0006-8993(87)80014-8
4. American Psychiatric Association. (2013). DSM 5. Washington, DC:American Psychiatric Association
5. Angrist, B. M., and Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol. Psychiatry2, 95-107.
6. Aoki, C., Venkatesan, C., Go, C., Mong, J. A., and Dawson, T. M. (1994). Cellular and subcellular localization of nmda-r1subunit immunoreactivity in the visual cortex of adult and neonatal rats.J. Neurosci.14, 5202-5222.
7. Aoki, Y., Orikabe, L., Takayanagi, Y., Yahata, N., Mozue, Y., Sudo, Y., et al. (2013). Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis. Schizophr. Res.147, 355-361. doi: 10.1016/j. schres.2013.04.029
8. Arai, S., Takuma, K., Mizoguchi, H., Ibi, D., Nagai, T., Kamei, H., et al. (2009). Gabab receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice. Eur. J. Pharmacol.602, 101-104. doi: 10.1016/j.ejphar.2008. 10.065
9. Armstrong, B. D., and Noguchi, K. K. (2004). The neurotoxic effects of 3,4-methylenedioxymethamphetamine (mdma) and methamphetamine on serotonin, dopamine, and gaba-ergic terminals: anin-vitroautoradiographic study in rats. Neurotoxicology25, 905-914. doi: 10.1016/j.neuro.2004.06.003
10. Balla, A., Nattini, M. E., Sershen, H., Lajtha, A., Dunlop, D. S., and Javitt, D. C. (2009). Gabab/nmda receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology 56, 915-921. doi: 10.1016/j.neuropharm.2009.01.021
11. Balleine, B. W., Delgado, M. R., and Hikosaka, O. (2007). The role of the dorsal striatum in reward and decision-making. J. Neurosci. 27, 8161-8165. doi: 10.1523/JNEUROSCI.1554-07.2007
12. Batki, S. L., and Harris, D. S. (2004). Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am. J. Addict.13, 461-470. doi: 10.1080/10550490490512834
13. Bell, D. S. (1965). Comparison of amphetamine psychosis and schizophrenia. Br. J. Psychiatry111, 701-707. doi: 10.1192/bjp.111.477.701
14. Bell, D. S. (1973). The experimental reproduction of amphetamine psychosis. Arch. Gen. Psychiatry29, 35-40. doi: 10.1001/archpsyc.1973.04200010020003
15. Bellomo, M., Giuffrida, R., Palmeri, A., and Sapienza, S. (1998). Excitatory amino acids as neurotransmitters of corticostriatal projections: immunocytochemical evidence in the rat. Arch. Ital. Biol.136, 215-223.
16. Benes, F. M., and Berretta, S. (2001). Gabaergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27. doi: 10.1016/S0893-133X(01)00225-1
17. Bramness, J. G., Gundersen, O. H., Guterstam, J., Rognli, E. B., Konstenius, M., Loberg, E. M., et al. (2012). Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable?BMC Psychiatry 12:221. doi: 10.1186/1471-244X-12-221
18. Bu, Q., Lv, L., Yan, G., Deng, P., Wang, Y., Zhou, J., et al. (2013). Nmrbased metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology36, 17-23. doi: 10.1016/j.neuro.2013.02.007
19. Burns, L. (2014). World drug report 2013 by united nations office on drugs and crime new york: United nations, 2013isbn: 978-92-1-056168-6, 151 pp. grey literature. Drug Alcohol Rev.33, 216-216. doi: 10.1111/dar.12110
20. Bustamante, D., You, Z.-B., Castel, M.-N., Johansson, S., Goiny, M., Terenius, L., et al. (2002). Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.J. Neurochem.83, 645-654. doi: 10.1046/j.1471-4159.2002.01171.x
21. Cadet, J. L., and Krasnova, I. N. (2009). Molecular bases of methamphetamineinduced neurodegeneration. Int. Rev. Neurobiol. 88, 101-119. doi: 10.1016/S0074-7742(09)88005-7
22. Cartier, J., Farabee, D., and Prendergast, M. L. (2006). Methamphetamine use, self-reported violent crime, and recidivism among offenders in california who abuse substances.J. Interpers. Violence 21, 435-445. doi: 10.1177/088626050 5285724
23. Castner, S. A., al Tikriti, M. S., Baldwin, R. M., Seibyl, J. P., Innis, R. B., and Goldman-Rakic, P. S. (2000). Behavioral changes and [123i]ibzm equilibrium spect measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine. Neuropsychopharmacology22, 4-13. doi: 10.1016/S0893-133X(99)00080-9
24. Castner, S. A., and Goldman-Rakic, P. S. (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology 20, 10-28. doi: 10.1016/S0893-133X(98) 00050-5
25. Castner, S. A., Vosler, P. S., and Goldman-Rakic, P. S. (2005). Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biol. Psychiatry57, 743-751. doi: 10.1016/j.biopsych.2004. 12.019
26. Cepeda, C., and Levine, M. S. (1998). Dopamine and n-methyl-d-aspartate receptor interactions in the neostriatum. Dev. Neurosci.20, 1-18. doi: 10.1159/000017294
27. Chang, L., Alicata, D., Ernst, T., and Volkow, N. (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction102(Suppl. 1), 16-32. doi: 10.1111/j.1360-0443.2006.01782.x
28. Chen, C.K., Lin, S.K., Sham, P.C., Ball, D., Loh, E.W., Hsiao, C.C., et al. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol. Med.33, 1407-1414. doi: 10.1017/S0033291703008353
29. Chung, Y. A., Peterson, B. S., Yoon, S. J., Cho, S. N., Chai, S., Jeong, J., et al. (2010). In vivo evidence for long-term cns toxicity, associated with chronic binge use of methamphetamine. Drug Alcohol Depend.111, 155-160. doi: 10.1016/j.drugalcdep.2010.04.005
30. Colfax, G., and Guzman, R. (2006). Club drugs and hiv infection: a review. Clin. Infect. Dis.42, 1463-1469. doi: 10.1086/503259
31. Connell, P. H. (1958). Amphetamine Psychosis. London: Chapman & Hall.
32. Cornish, J. L., and Kalivas, P. W. (2000). Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction.J. Neurosci.20:RC89.
33. Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., and Hall, J. A. (2003). Treatment of methamphetamine abuse: research findings and clinical directions.J. Subst. Abuse Treat.24, 267-277. doi: 10.1016/S0740-5472(03)00028-X
34. Cruickshank, C. C., and Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction104, 1085-1099. doi: 10.1111/j.1360-0443.2009.02564.x
35. Curran, C., Byrappa, N., and McBride, A. (2004). Stimulant psychosis: systematic review. Br. J. Psychiatry185, 196-204. doi: 10.1192/bjp.185.3.196
36. Daskalakis, Z. J., Fitzgerald, P. B., and Christensen, B. K. (2007). The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res. Rev.56, 427-442. doi: 10.1016/j.brainresrev.2007.09.006
37. Davidson, C., Gow, A. J., Lee, T. H., and Ellinwood, E. H. (2001). Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev.36, 1-22. doi: 10.1016/S0165-0173(01)00054-6
38. DeFelipe, J. (2001). Cortical interneurons: from cajal to 2001. Progress Brain Res. 136, 215-238. doi: 10.1016/S0079-6123(02)36019-9
39. Deng, X., Huang, Z., Li, X., Li, Y., Wang, Y., Wu, D., et al. (2012). Long-term follow-up of patients treated for psychotic symptoms that persist after stopping illicit drug use. Shanghai Arch. Psychiatry24, 271-278. doi: 10.3969/j.issn.1002-0829.2012.05.004
40. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S. F. (1999). The glutamate receptor ion channels. Pharmacol. Rev.51, 7-61.
41. Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., et al. (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry49, 81-96. doi: 10.1016/S0006-3223(00)01038-6
42. Ernst, T., Chang, L., Leonido-Yee, M., and Speck, O. (2000). Evidence for longterm neurotoxicity associated with methamphetamine abuse: a 1h mrs study. Neurology54, 1344-1349. doi: 10.1212/WNL.54.6.1344
43. Fallon, J. H., and Moore, R. Y. (1978). Catecholamine innervation of the basal forebrain iv. topography of the dopamine projection to the basal forebrain and neostriatum.J. Comp. Neurol.180, 545-579. doi: 10.1002/cne.901800310
44. Farrell, M., Marsden, J., Ali, R., and Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the asia pacific region. Addiction97, 771-772. doi: 10.1046/j.1360-0443.2002.00195.x
45. Featherstone, R., Kapur, S., and Fletcher, P. (2007). The amphetamine-induced sensitized state as a model of schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry31, 1556-1571. doi: 10.1016/j.pnpbp.2007.08.025
46. Forrest, A. D., Coto, C. A., and Siegel, S. J. (2014). Animal models of psychosis: current state and future directions. Curr. Behav. Neurosci. Rep.1, 100-116. doi: 10.1007/s40473-014-0013-2
47. Fowler, J. S., Volkow, N. D., Logan, J., Alexoff, D., Telang, F., Wang, G. J., et al. (2008). Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. Neuroimage43, 756-763. doi: 10.1016/j.neuroimage.2008.07.020
48. Gabernet, L., Jadhav, S. P., Feldman, D. E., Carandini, M., and Scanziani, M. (2005). Somatosensory integration controlled by dynamic thalamocortical feedforward inhibition. Neuron48, 315-327. doi: 10.1016/j.neuron.2005.09.022
49. Gaspar, P., Bloch, B., and Moine, C. (1995). D1 and d2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci.7, 1050-1063. doi: 10.1111/j.1460-9568.1995.tb01092.x
50. Gentet, L. J. (2012). Functional diversity of supragranular gabaergic neurons in the barrel cortex. Front. Neural Circuits6:52. doi: 10.3389/fncir.2012.00052
51. Gerfen, C. R. (1989). The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science246, 385-388. doi: 10.1126/science.2799392
52. Giorgetti, M., Hotsenpiller, G., Froestl, W., and Wolf, M. (2002). In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local gabab receptors is altered after repeated amphetamine treatment. Neuroscience109, 585-595. doi: 10.1016/S0306-4522(01)00510-3
53. Gold, J. M. (2004). Cognitive deficits as treatment targets in schizophrenia. Schizophr. Res.72, 21-28. doi: 10.1016/j.schres.2004.09.008
54. Goldberg, J. H., Tamas, G., Aronov, D., and Yuste, R. (2003a). Calcium microdomains in aspiny dendrites. Neuron40, 807-821. doi: 10.1016/S0896-6273(03)00714-1
55. Goldberg, J. H., Yuste, R., and Tamas, G. (2003b). Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of ca2+-permeable ampa and nmda receptors to subthreshold ca2+dynamics.J. Physiol.551(pt 1), 67-78. doi: 10.1113/jphysiol.2003.042598
56. Goldman-Rakic, P. S. (1994). Working memory dysfunction in schizophrenia.J. Neuropsychiatry Clin. Neurosci.6, 348-357.
57. Goldman-Rakic, P. S. (1995). Cellular basis of working memory. Neuron14, 477-485. doi: 10.1016/0896-6273(95)90304-6
58. Goldman-Rakic, P. S., Castner, S. A., Svensson, T. H., Siever, L. J., and Williams, G. V. (2004). Targeting the dopamine d1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology174, 3-16. doi: 10.1007/s00213-004-1793-y
59. Goldman-Rakic, P. S., Leranth, C., Williams, S. M., Mons, N., and Geffard, M. (1989). Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 86, 9015-9019. doi: 10.1073/pnas.86.22.9015
60. Gonon, F. (1988). Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied byin vivo electrochemistry. Neuroscience24, 19-28. doi: 10.1016/0306-4522(88)90307-7
61. Graveland, G. A., Williams, R. S., and DiFiglia, M. (1985). A golgi study of the human neostriatum: neurons and afferent fibers.J. Comp. Neurol.234, 317-333. doi: 10.1002/cne.902340304
62. Green, A. I., and Halkitis, P. N. (2006). Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity. Cult. Health Sex.8, 317-333. doi: 10.1080/13691050600783320
63. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia?Am.J. Psychiatry153, 321-330.
64. Haber, S. N., and Knutson, B. (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology35, 4-26. doi: 10.1038/npp.2009.129
65. Haber, S. N., and McFarland, N. R. (1999). The concept of the ventral striatum in nonhuman primates. Ann. N.Y. Acad. Sci.877, 33-48. doi: 10.1111/j.1749-6632.1999.tb09259.x
66. Halkitis, P. N., Parsons, J. T., and Stirratt, M. J. (2001). A double epidemic: crystal methamphetamine drug use in relation to hiv transmission among gay men.J. Homosexual.41, 17-35. doi: 10.1300/J082v41n02_02
67. Hardingham, G. E., and Bading, H. (2010). Synaptic versus extrasynaptic nmda receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci.11, 682-696. doi: 10.1038/nrn2911
68. Hardingham, G. E., Fukunaga, Y., and Bading, H. (2002). Extrasynaptic nmdars oppose synaptic nmdars by triggering creb shut-off and cell death pathways. Nat. Neurosci.5, 405-414. doi: 10.1038/nn835
69. Homayoun, H., and Moghaddam, B. (2006). Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine. J. Neurosci. 26, 8025-8039. doi: 10.1523/JNEUROSCI.0842-06.2006
70. Horan, W. P., Green, M. F., Knowlton, B. J., Wynn, J. K., Mintz, J., and Nuechterlein, K. H. (2008). Impaired implicit learning in schizophrenia. Neuropsychology22, 606-617. doi: 10.1037/a0012602
71. Howells, F. M., Uhlmann, A., Temmingh, H., Sinclair, H., Meintjes, E., Wilson, D., et al. (2014). 1h-magnetic resonance spectroscopy (1h-mrs) in methamphetamine dependence and methamphetamine induced psychosis. Schizophr. Res.153, 122-128. doi: 10.1016/j.schres.2014.01.029
72. Hu, X. T., and White, F. J. (1997). Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of d1 and d2 class receptors. Neurosci. Lett.224, 61-65. doi: 10.1016/S0304-3940(97) 13443-7
73. Huntley, G. W., Vickers, J., Janssen, W., Brose, N., Heinemann, S., and Morrison, J. (1994). Distribution and synaptic localization of immunocytochemically identified nmda receptor subunit proteins in sensory-motor and visual cortices of monkey and human.J. Neurosci.14, 3603-3619.
74. Iwanami, A., Kato, N., and Nakatani, Y. (1991). P300 in methamphetamine psychosis. Biol. Psychiatry 30, 726-730. doi: 10.1016/0006-3223(91) 90018-H
75. Iwanami, A., Kuroki, N., Iritani, S., Isono, H., Okajima, Y., andKamijima, K. (1998). P3a of event-related potential in chronic methamphetamine dependence.J. Nerv. Ment. Dis. 186, 746-751. doi: 10.1097/00005053-199812000-00002
76. Iwanami, A., Suga, I., Kato, N., Nakatani, Y., and Kaneko, T. (1993). Event-related potentials in methamphetamine psychosis during an auditory discrimination task. a preliminary report. Eur. Arch. Psychiatry Clin. Neurosci.242, 203-208. doi: 10.1007/BF02189964
77. Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., et al. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in japan. a preliminary report. Acta Psychiat. Scand.89, 428-432. doi: 10.1111/j.1600-0447.1994.tb01541.x
78. Iyo, M., Namba, H., Yanagisawa, M., Hirai, S., Yui, N., and Fukui, S. (1997). Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99mtc-hmpao and spect. Prog. Neuro-psychopharmacol. Biol. Psychiatry 21, 789-796. doi: 10.1016/S0278-5846(97)00079-1
79. Jackson, M. E., Homayoun, H., and Moghaddam, B. (2004). Nmda receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A.101, 8467-8472. doi: 10.1073/pnas.0308455101
80. Jacobs, E., Fujii, D., Schiffman, J., and Bello, I. (2008). An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia. Cogn. Behav. Neurol. 21, 98-103. doi: 10.1097/WNN.0b013e31816bdf90
81. Janowsky, D. S., and Risch, C. (1979). Amphetamine psychosis and psychotic symptoms. Psychopharmacology65, 73-77. doi: 10.1007/BF00491982
82. Jones, E. G. (1993). Gabaergic neurons and their role in cortical plasticity in primates. Cereb. Cortex3, 361-372. doi: 10.1093/cercor/3.5.361-a
83. Kalivas, P. W., and Volkow, N. D. (2005). The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry162, 1403-1413. doi: 10.1176/appi.ajp.162.8.1403
84. Kamei, H., Nagai, T., Nakano, H., Togan, Y., Takayanagi, M., Takahashi, K., et al. (2006). Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced erk1/2 activation in the prefrontal cortex of mice. Biol. Psychiatry59, 75-84. doi: 10.1016/j.biopsych.2005.06.006
85. Kankaanpää, A., Meririnne, E., Lillsunde, P., and Seppälä, T. (1998). The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol. Biochem. Behav.59, 1003-1009. doi: 10.1016/S0091-3057(97)00527-3
86. Kaufman, A. M., Milnerwood, A. J., Sepers, M. D., Coquinco, A., She, K., Wang, L., et al. (2012). Opposing roles of synaptic and extrasynaptic nmda receptor signaling in cocultured striatal and cortical neurons.J. Neurosci.32, 3992-4003. doi: 10.1523/JNEUROSCI.4129-11.2012
87. Kawaguchi, Y. (1995). Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer ii/iii of rat frontal cortex.J. Neurosci.15, 2638-2655.
88. Kemp, J. M., and Powell, T. P. (1970). The cortico-striate projection in the monkey. Brain J. Neurol.93, 525-546. doi: 10.1093/brain/93.3.525
89. Kittirattanapaiboon, P., Mahatnirunkul, S., Booncharoen, H., Thummawomg, P., Dumrongchai, U., and Chutha, W. (2010). Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev.29, 456-461. doi: 10.1111/j.1465-3362.2010.00196.x
90. Koob, G. F., and Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science242, 715-723. doi: 10.1126/science.2903550
91. Kuczenski, R., Everall, I. P., Crews, L., Adame, A., Grant, I., and Masliah, E. (2007). Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp. Neurol.207, 42-51. doi: 10.1016/j.expneurol.2007.05.023
92. Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., et al. (2003). Patterns of selective neuronal damage in methamphetamine-user aids patients.J. Acquir. Immune Defic. Syndr.34, 467-474. doi: 10.1097/00126334-200312150-00004
93. Lee, K. W., Kim, H. C., Lee, S. Y., and Jang, C. G. (2011). Methamphetaminesensitized mice are accompanied by memory impairment and reduction of n-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience178, 101-107. doi: 10.1016/j.neuroscience.2011.01.025
94. Lewis, D. A., Curley, A. A., Glausier, J. R., and Volk, D. W. (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neuros c i. 35, 57-67. doi: 10.1016/j.tins.2011.10.004
95. Lewis, D. A., Volk, D. W., and Hashimoto, T. (2004). Selective alterations in prefrontal cortical gaba neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology174, 143-150. doi: 10.1007/s00213-003-1673-x
96. Liu, X., Chang, L., Vigorito, M., Kass, M., Li, H., and Chang, S. L. (2009). Methamphetamine-induced behavioral sensitization is enhanced in the hiv-1 transgenic rat. J. Neuroimmune Pharmacol. 4, 309-316. doi: 10.1007/s11481-009-9160-8
97. Machiyama, Y. (1992). Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr. Bull.18, 107-113. doi: 10.1093/schbul/ 18.1.107
98. Mahoney, J. J., Kalechstein, A. D., Garza, R. D. L., and Newton, T. F. (2008). Presence and persistence of psychotic symptoms in cocaine-versus methamphetamine-dependent participants. Am.J. Addict.17, 83-98. doi: 10.1080/10550490701861201
99. Mark, K. A., Quinton, M. S., Russek, S. J., and Yamamoto, B. K. (2007). Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release.J. Neurosci.27, 6823-6831. doi: 10.1523/JNEUROSCI.0013-07.2007
100. Mark, K. A., Soghomonian, J. J., and Yamamoto, B. K. (2004). High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.J. Neurosci.24, 11449-11456. doi: 10.1523/JNEUROSCI.3597-04.2004
101. Maurice, N., Deniau, J.-M., Glowinski, J., and Thierry, A.-M. (1999). Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits.J. Neurosci.19, 4674-4681.
102. McKetin, R., Hickey, K., Devlin, K., and Lawrence, K. (2010). The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alcohol Rev.29, 358-363. doi: 10.1111/j.1465-3362.2009.00160.x
103. McKetin, R., McLaren, J., Lubman, D. I., and Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction101, 1473-1478. doi: 10.1111/j.1360-0443.2006.01496.x
104. Medhus, S., Mordal, J., Holm, B., Mørland, J., and Bramness, J. G. (2013). A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Res.206, 17-21. doi: 10.1016/j.psychres.2012. 09.023
105. Mizoguchi, H., and Yamada, K. (2011). Pharmacologic treatment with gabab receptor agonist of methamphetamine-induced cognitive impairment in mice. Curr. Neuropharmacol.9, 109. doi: 10.2174/157015911795016976
106. Mogenson, G. J., Jones, D. L., and Yim, C. Y. (1980). From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol.14, 69-97. doi: 10.1016/0301-0082(80)90018-0
107. Muly, E. C., Szigeti, K., and Goldman-Rakic, P. S. (1998). D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization.J. Neurosci.18, 10553-10565.
108. Nagai, T., Takuma, K., Dohniwa, M., Ibi, D., Mizoguchi, H., Kamei, H., et al. (2007). Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology194, 21-32. doi: 10.1007/s00213-007-0820-1
109. Nagai, T., and Yamada, K. (2010). Molecular mechanism for methamphetamineinduced memory impairment. Nihon Arukoru Yakubutsu Igakkai zasshi45, 81-91.
110. Nicola, S. M. (2007). The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology191, 521-550. doi: 10.1007/s00213-006-0510-4
111. Nordahl, T. E., Salo, R., Possin, K., Gibson, D. R., Flynn, N., Leamon, M., et al. (2002). Low n-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton mrs study. magnetic resonance spectroscopy. Psychiatry Res.116, 43-52. doi: 10.1016/S0925-4927(02)00088-4
112. Padgett, C. L., Lalive, A. L., Tan, K. R., Terunuma, M., Munoz, M. B., Pangalos, M. N., et al. (2012). Methamphetamine-evoked depression of gaba(b) receptorsignalingingabaneuronsofthevta. Neuron73, 978-989. doi: 10.1016/j.neuron.2011.12.031
113. Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., et al. (2013). Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend.129, 167-179. doi: 10.1016/j.drugalcdep.2012.11.016
114. Papadia, S., and Hardingham, G. E. (2007). The dichotomy of nmda receptor signaling. Neuroscientist13, 572-579. doi: 10.1177/1073858407305833
115. Paulson, P. E., and Robinson, T. E. (1995). Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19, 56-65. doi: 10.1002/syn.890190108
116. Petralia, R., Yokotani, N., and Wenthold, R. (1994a). Light and electron microscope distribution of the nmda receptor subunit nmdar1 in the rat nervous system using a selective anti-peptide antibody.J. Neurosci.14, 667-696.
117. Petralia, R. S., Wang, Y. X., and Wenthold, R. J. (1994b). The nmda receptor subunits nr2a and nr2b show histological and ultrastructural localization patterns similar to those of nr1.J. Neurosci.14, 6102-6120.
118. Petralia, R. S. (2012). Distribution of extrasynaptic NMDA receptors on neurons. ScientificWorldJournal2012:267120. doi: 10.1100/2012/267120
119. Plüddemann, A., Flisher, A. J., McKetin, R., Parry, C., and Lombard, C. (2010). Methamphetamine use, aggressive behavior and other mental health issues among high-school students in cape town, south africa. Drug Alcohol Depend. 109, 14-19. doi: 10.1016/j.drugalcdep.2009.11.021
120. Reiner, B. C., Keblesh, J. P., and Xiong, H. (2009). Methamphetamine abuse, hiv infection, and neurotoxicity. Int. J. Physiol. Pathophysiol. Pharmacol.1, 162-179.
121. Reubi, J. C., Iversen, L. L., and Jessell, T. M. (1977). Dopamine selectively increases 3h-gaba release from slices of rat substantia nigrain vitro. Nature268, 652-654. doi: 10.1038/268652a0
122. Reubi, J. C., Iversen, L. L., and Jessell, T. M. (1978). Regulation of gaba release by dopamine in the rat substantia nigra. Adv. Biochem. Psychopharmacol.19, 401-404.
123. Robinson, T. E., and Becker, J. B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res.396, 157-198. doi: 10.1016/0165-0173(86)90002-0
124. Robinson, T. E., and Kolb, B. (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.J. Neurosci.17, 8491-8497.
125. Robinson, T. E., and Kolb, B. (1999). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci.11, 1598-1604. doi: 10.1046/j.1460-9568.1999.00576.x
126. Rymar, V. V., Sasseville, R., Luk, K. C., and Sadikot, A. F. (2004). Neurogenesis and stereological morphometry of calretinin-immunoreactive gabaergic interneurons of the neostriatum. J. Comp. Neurol. 469, 325-339. doi: 10.1002/cne. 11008
127. Salamone, J. D., Correa, M., Farrar, A., and Mingote, S. M. (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology191, 461-482. doi: 10.1007/s00213-006-0668-9
128. Sato, M., Numachi, Y., and Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull.18, 115-122. doi: 10.1093/schbul/18.1.115
129. Schroder, N., O'Dell, S. J., and Marshall, J. F. (2003). Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse49, 89-96. doi: 10.1002/syn.10210
130. Scott, J.C., Woods, S.P., Matt, G.E., Meyer, R.A., Heaton, R.K., Atkinson, J.H., et al. (2007). Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev.17, 275-297. doi: 10.1007/s11065-007-9031-0
131. Segal, D. S., and Kuczenski, R. (1997). An escalating dose binge model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci.17, 2551-2566.
132. Segal, D. S., and Kuczenski, R. (2001). "Escalating dose-binge exposure to amphetamine and methamphetamine: behavioral and neurochemical characterization, " in Contemporary Neuropsychiatry, eds K. Miyoshi, C. Shapiro, M. Gaviria, and Y. Morita (Springer), 330-335.
133. Sekine, Y., Minabe, Y., Kawai, M., Suzuki, K., Iyo, M., Isoda, H., et al. (2002). Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. a proton mrs study. Neuropsychopharmacology27, 453-461. doi: 10.1016/S0893-133X(02)00321-4
134. Selemon, L. D., Begovic, A., Goldman-Rakic, P. S., and Castner, S. A. (2007). Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate. Neuropsychopharmacology32, 919-931. doi: 10.1038/sj.npp.1301179
135. Silber, B. Y., Croft, R. J., Papafotiou, K., and Stough, C. (2006). The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology187, 154-169. doi: 10.1007/s00213-006-0410-7
136. Simon, H., Scatton, B., and Le Moal, M. (1980). Dopaminergic A10 neurones are involved in cognitive functions. Nature286, 150-151. doi: 10.1038/286150a0
137. Sirinathsinghji, D., Dunnett, S., Isacson, O., Clarke, D., Kendrick, K., and Björklund, A. (1988). Striatal grafts in rats with unilateral neostriatal lesionsâ A Tii. sin vivo monitoring of gaba release in globus pallidus and substantia nigra. Neuroscience24, 803-811. doi: 10.1016/0306-4522(88)90068-1
138. Sora, I., Li, B., Fumushima, S., Fukui, A., Arime, Y., Kasahara, Y., et al. (2009). Monoamine transporter as a target molecule for psychostimulants. Int. Rev. Neurobiol.85, 29-33. doi: 10.1016/S0074-7742(09)85003-4
139. Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., and Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. Int. J. Neuropsychopharmacol.6, 347-352. doi: 10.1017/S1461145703003675
140. Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., and Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry35, 959-964. doi: 10.1016/j.pnpbp. 2011.01.014
141. Stephans, S. E., and Yamamoto, B. K. (1994). Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse17, 203-209. doi: 10.1002/syn.890170310
142. Stephans, S. E., and Yamamoto, B. Y. (1995). Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res.700, 99-106. doi: 10.1016/0006-8993(95)00938-M
143. Sulzer, D., Chen, T. K., Lau, Y. Y., Kristensen, H., Rayport, S., and Ewing, A. (1995). Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.J. Neurosci.15(5 pt 2), 4102-4108.
144. Surmeier, D. J., Ding, J., Day, M., Wang, Z., and Shen, W. (2007). D1 and d2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neuros c i.30, 228-235. doi: 10.1016/j.tins.2007. 03.008
145. Tepper, J. M., and Bolam, J. P. (2004). Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol.14, 685-692. doi: 10.1016/j.conb.2004. 10.003
146. Timmerman, W., and Westerink, B. H. (1997). Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular gaba in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats. Synapse26, 62-71. doi: 10.1002/(SICI)1098-2396(199705)26:1<62::AIDSYN7>3.0.CO;2-C
147. Tomiyama, G. (1990). Chronic schizophrenia-like states in methamphetamine psychosis. Japan. J. Psychiatry Neurol.44, 531-539.
148. Tzschentke, T. (2001). Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol.63, 241-320. doi: 10.1016/S0301-0082(00)00033-2
149. Ujike, H., and Sato, M. (2004). Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N.Y. Acad. Sci.1025, 279-287. doi: 10.1196/annals.1316.035
150. United Nations Office. (2011). "World drug report 2011, " inTechnical Report (Vienna: United Nations Publications).
151. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Ding, Y. S., Sedler, M., et al. (2001a). Low level of brain dopamine d2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry158, 2015-2021. doi: 10.1176/appi.ajp.158.12.2015
152. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am.J. Psychiatry158, 377-382. doi: 10.1176/appi.ajp.158.3.377
153. Volkow, N. D., Wang, G. J., Fowler, J. S., Gatley, S. J., Ding, Y. S., Logan, J., et al. (1996). Relationship between psychostimulant-induced high and dopamine transporter occupancy. Proc. Natl. Acad. Sci. U.S.A.93, 10388-10392. doi: 10.1073/pnas.93.19.10388
154. Weich, L., and Pienaar, W. (2009). Occurrence of comorbid substance use disorders among acute psychiatric inpatients at stikland hospital in the western cape, south africa. Afr. J. Psychiatry12, 213-217. doi: 10.4314/ajpsy.v12i3.48496
155. Williams, S., and Goldman-Rakic, P. (1998). Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex8, 321-345. doi: 10.1093/cercor/8.4.321
156. Wilson, C. J. (1993). The generation of natural firing patterns in neostriatal neurons. Prog. Brain Res.99, 277-297. doi: 10.1016/S0079-6123(08)61352-7
157. Wilson, C. J., and Kawaguchi, Y. (1996). The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons.J. Neurosci.16, 2397-2410.
158. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., et al. (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med.2, 699-703. doi: 10.1038/ nm0696-699
159. Xue, C.-J., Ng, J. P., Li, Y., and Wolf, M. E. (1996). Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67, 352-363. doi: 10.1046/j.1471-4159.1996. 67010352.x
160. Yin, H. H., and Knowlton, B. J. (2006). The role of the basal ganglia in habit formation. Nat. Rev. Neurosci.7, 464-476. doi: 10.1038/nrn1919
161. Yui, K., Ishiguro, T., Goto, K., and Ikemoto, S. (1997). Precipitating factors in spontaneous recurrence of methamphetamine psychosis. Psychopharmacology134, 303-308. doi: 10.1007/s002130050453
162. Yui, K., Ishiguro, T., Goto, K., Ikemoto, S., and Kamata, Y. (1999). Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change. Eur. Arch. Psychiatry Clin. Neurosci.249, 103-111. doi: 10.1007/s004060050073
163. Zhang, Y., Loonam, T. M., Noailles, P.-A., and Angulo, J. A. (2001). Comparison of cocaine-and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N.Y. Acad. Sci.937, 93-120. doi: 10.1111/j.1749-6632.2001.tb03560.x